Last reviewed · How we verify
NCT05885178: TRACK-LVO-1
Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-1 (TRACK-LVO-1)
trial testing Endovascular Therapy in Stroke, Acute Ischemic in 5,000 participants. Status unknown.
1 November 2021
Quick facts
| Lead sponsor | Tianjin Huanhu Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 1 January 2018 |
| Primary completion | 1 November 2021 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Endovascular Therapy
Conditions studied
- Stroke, Acute Ischemic — all drugs for Stroke, Acute Ischemic →
- Endovascular Procedures — all drugs for Endovascular Procedures →
- Large Vessel Occlusion — all drugs for Large Vessel Occlusion →
Sponsor
Tianjin Huanhu Hospital
Who can join
18 and older, any sex, with Stroke, Acute Ischemic or Endovascular Procedures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to establish an academic, real-world, single-center, observational registry of consecutive patients hospitalized with acute ischemic stroke (AIS) due to large vessel occlusions (LVO), treated with either endovascular therapy (EVT) or best medical management (BMM).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05885178
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Endovascular Therapy
Trials testing the same drug.
- NCT07345702 — Basilar Artery Occlusion Chinese Endovascular Registry in Patients With Large-Core Infarct · not yet recruiting
- NCT05029414 — EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke · NA · active not recruiting
- NCT05659160 — Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2 · recruiting
- NCT04675632 — Impact of Tibial Run Off on Clinical Outcome of Endovascular Therapy in Femoropopliteal Lesions (TALENT Study) · completed
- NCT06094569 — Medical Imaging Screening for Posterior-circulation Ischemic Stroke · recruiting
Other recruiting trials for Stroke, Acute Ischemic
Currently open trials in the same condition.
- NCT06987305 — Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window · Phase 3 · recruiting
- NCT06768138 — Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke · Phase 3 · recruiting
- NCT06388148 — Endovascular Treatment for eXtra-Large Ischemic Stroke · NA · recruiting
- NCT06374667 — The Efficacy and Safety of Y-3 Intracalvariosseous Injection Versus Intravenous Injection in the Treatment of Acute Larg · NA · recruiting
- NCT06010641 — Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES · NA · recruiting
Other Tianjin Huanhu Hospital trials
Trials by the same sponsor.
- NCT07386015 — Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG) · recruiting
- NCT07365475 — Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke · Phase 2 · not yet recruiting
- NCT07294391 — The Preliminary Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic St · Phase 2 · not yet recruiting
- NCT07115511 — Combined Recanalization Therapy for Acute Large Vessel Occlusion Stroke · NA · recruiting
- NCT06621121 — A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Strok · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05885178 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tianjin Huanhu Hospital
- Last refreshed: 29 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05885178.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing